Stimulants in 2026: Meth, Cocaine, and the Prescription Shadow
The fourth wave of the crisis is stimulant-driven. And there's still no FDA-approved medication for stimulant use disorder.
Body — 8 lenses: [Science: monoamine release/reuptake (DA, NE, serotonin) — cocaine blocks; meth releases. Biology: hyperthermia, cardiac strain, neurotoxicity (dopamine terminals with chronic high-dose meth), dental effects (“meth mouth” from dry-mouth + acidic diet, not the drug directly). Psychology: the “euphoria gap” after the acute phase, stimulant psychosis in heavy meth use, ADHD/stimulant diagnosis intersection. Policy: Schedule II (meth, cocaine, Rx stimulants); DEA production quotas; Adderall shortage backstory. Trends: stimulant-involved deaths hit 57,500 in 2022, ~70% co-involving fentanyl — the fourth wave. Social: the crack-era racialized policy legacy and current disparities. Treatment: NO FDA-approved medication for stimulant UD; contingency management has the strongest evidence (RCTs 2–4× retention); CBT, community reinforcement, matrix model. Harm reduction: sleep, hydration, avoiding mixing with depressants, safer-use supplies, drug checking.]
Sources Cited
- 01.A
- 02.A
Filed Under
sciencebiologypsychologypolicytrendssocial-culturaltreatmentharm-reductionPeer-Reviewed Research
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The Ozempic-for-Drinking Trial Just Published Real Numbers. The Headline Effect Missed Its Own Primary Target.
A Phase 2 trial of oral semaglutide for alcohol use disorder found real reductions in heavy drinking days and craving — but missed its own pre-registered primary endpoint. Here's what that gap means, and why the VA is running the next version now.
Science & Medicine45 Million Americans Have a Substance Use Disorder Right Now. The Government's Own Survey Says So — and Says Most Won't Get Treated.
SAMHSA's 2025 NSDUH shows 45 million Americans met SUD criteria in the past year — 15.3% of everyone 12 and older. Here's what the numbers actually say.
Science & MedicineNicotine Pouches Didn't Slip Past Public Health. They Got Rebranded as Self-Optimization
Nicotine pouch shipments grew 37% in a year almost entirely outside the frame most youth-prevention conversations are still having. Here's how gym-bro TikTok culture, not tobacco advertising, built that growth.